Other Barks & Bites for Friday, March 20: CAFC Approves Flexible Domestic Industry Analysis at ITC; MFN Pricing Threatens $167 Trillion in Medical Innovation's Societal Value; and UK Has No Preferred Option for AI and Copyright
Briefly

Other Barks & Bites for Friday, March 20: CAFC Approves Flexible Domestic Industry Analysis at ITC; MFN Pricing Threatens $167 Trillion in Medical Innovation's Societal Value; and UK Has No Preferred Option for AI and Copyright
"The Federal Circuit okays the U.S. International Trade Commission's flexible analysis of the technical and economic prongs of the domestic industry requirement, indicating a shift towards adaptability in regulatory assessments."
"The University of California tops the National Academy of Inventors list of top universities obtaining U.S. utility patents last year, showcasing its leadership in innovation and patent acquisition."
"The EU's highest court rules that first requests for data access under the General Data Protection Regulation may be excessive if part of a systemic pattern of entering data claims for compensation, emphasizing the need for balanced data access."
"A recent economic study shows that U.S. medical innovation has contributed $167 trillion in societal value over three decades, highlighting the significant impact of innovation on society and the economy."
The Federal Circuit has approved the U.S. International Trade Commission's flexible approach to analyzing domestic industry requirements. The University of California leads in U.S. utility patents. The EU's highest court ruled that initial data access requests under GDPR can be excessive if aimed solely at compensation claims. The UK's Technology Secretary stated there is no preferred approach for AI and copyright issues. A study revealed U.S. medical innovation has generated $167 trillion in societal value over 30 years. The FTC will monitor pharmaceutical market behaviors as key patents expire.
[
|
]